2014 Annual Meeting | 6CS.004 - Case Studies: Multiple Sclerosis

Date Thursday 05/01/14

Time 06:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Extended Seminar

Director(s) Robert A. Bermel, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnoses, work-up, and treatment of MS and related conditions, including interpretation of MRI studies for MS and other disorders that affect the brain and spinal cord.

CME Available No CME available

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:00 PM - 07:30 PM		Cases and Discussion John Ratchford, MD, Robert A. Bermel, MD, FAAN
06:00 PM - 09:00 PM		Food & Beverage
07:30 PM - 07:45 PM		Break
07:45 PM - 09:00 PM		Cases and Discussion John Ratchford, MD, Robert A. Bermel, MD, FAAN

Faculty Disclosures
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
John Ratchford, MD	Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.